Published: 10:02am, 30 Jul, 2018 Updated: 11:01pm, 30 Jul, 2018
China's gene sequencing market is predicted to grow from CNY7.2bn ($1.06bn) last year to CNY18.3bn by 2022, thanks to increased investment from equipment makers and rising consumer income, according to Beijing-based CCID Consulting. The international market is currently worth $3bn, but Global Market Insights predicted it will expand to $22bn by 2024. It is good news for firms such as Tencent-backed Centrillion, which has developed third-generation DNA-sequencing semiconductor chips. It has two plants based in China and harbours ambitions of achieving annual revenues of $1bn.